S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS ST...

por Heeney1, Matthew, Rees, David, de Montalembert, Mariane, Odame, Isaac, Wali, Yasser, Sayyed, Sarfaraz, Shanmuganathan Muthusamy, Velusamy, Mendonza, Anisha E., Nassin, Michele, Keefe, Deborah, Kanter, Julie
Publicado 2023